Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized,Double-blind,Placebo-controlled, Multicenter Study of the Efficacy and Safety of Vaginal Misoprostol for Cervical Ripening and Induction of Labor

NCT01428037 is registered in ClinicalTrials.gov with Regenex Pharmaceutical, China as lead sponsor.

NCT NCT01428037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01428037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized,Double-blind,Placebo-controlled, Multicenter Study of the Efficacy and Safety of Vaginal Misoprostol for Cervical Ripening and Induction of Labor
Lead sponsor
Regenex Pharmaceutical, China
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2012
Completion date
January 31, 2013
Enrollment
225 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cervical ripening, induction of labor